Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. SPHERE Inc.
WARNING LETTER
•SPHERE Inc.

SPHERE Inc. – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to SPHERE Inc. on September 21, 2011, addressing the internet marketing of unapproved and misbranded drugs through numerous websites. The FDA determined that the company's websites offered products for sale in violation of multiple sections of the Federal Food, Drug, and Cosmetic Act (FD&C Act), including 301(a), 301(d), 303(e), 502(f), 503(b), and 505(a). Key violations included the introduction into interstate commerce of unapproved new drugs, such as "Viagra Professional," "Cialis Super Active," Acomplia, and Melanotan, for which no FDA-approved applications exist. The firm also unlawfully distributed human growth hormone (HGH) without a physician's order, a violation punishable by significant prison time and fines. Furthermore, SPHERE Inc. offered prescription drugs, including controlled substances, without requiring a valid prescription, leading to misbranding under section 503(b)(1). The labeling for many products failed to bear adequate directions for use, resulting in misbranding under section 502(f)(1). Specifically, misbranded Accutane (isotretinoin) was sold, bypassing critical safety controls like the iPLEDGE program, which places patients at risk. The FDA emphasized the inherent risks of unapproved and misbranded drugs from unregulated sources, citing concerns about safety, efficacy, quality, contamination, counterfeiting, and inconsistent active ingredients. SPHERE Inc. was instructed to immediately cease marketing all violative drug products and to respond in writing within 15 working days, detailing corrective actions and recurrence prevention measures. Failure to comply could result in regulatory actions such as seizure and injunction.

Company
SPHERE Inc.
Product type
Drugs
Office
Department of Health and Human Services
Person
  • Michael M. Levy
View Company Profile

ID · 1694eeb6-18df-4811-b313-36f60a6dff01

Violation Codes10
21 U.S.C. 353(b)(1)21 U.S.C. 321(g)21 U.S.C. 331(a)21 U.S.C. 331(d)21 U.S.C. 333(e)21.U.S.C. 355(a)21 CFR 201.11521 U.S.C. 321(p)FD&C Act 505(a)FD&C Act 301(d)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SPHERE Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.